BiotechTube
Home/Biond Biologics/Tehila Ben Moshe, Ph.D.
TB

Tehila Ben Moshe, Ph.D.

Co‑Founder, Chairperson & Chief Executive Officer

Biond Biologics

Therapeutic Areas

OncologyImmunology

Biond Biologics Pipeline

DrugIndicationPhase
BND-22 (SAR44481)Solid TumorsPhase 1/2
BND-35Solid TumorsPhase 1/2

Leadership Team at Biond Biologics

OS
Ori Shilo, MBA
Co‑Founder & Chief Financial Officer
YS
Yair Sapir, Ph.D., MBA
Chief Operations Officer
IM
Ilana Mandel, Ph.D.
Chief Scientific Officer
View full Biond Biologics profile